FST Solution goes into series production for a portable insulin pump

Share
YpsoPump

The Swiss medical technology specialist Ypsomed is introducing a new pump known as the mylife YpsoPump into the European market.

Type 1 diabetics are dependent on the steady flow of insulin. Portable insulin pumps allow an active, mobile life and can increase the quality of life of patients suffering from the condition.

The Swiss medical technology specialist Ypsomed is introducing a new pump known as the mylife YpsoPump into the European market. With a weight of just 83 grams—including the battery—and a thickness of just 16 mm, it is quite compact and comfortable to carry.

The proven “lube & seal” concept from Freudenberg Sealing Technologies and lubricant manufacturer Klüber Lubrication, which is part of the Freudenberg Group, ensures the pump’s flawless functioning over its four-year lifespan. It aims at the perfect interaction of seal and lubricant.

Portable insulin pumps continually transport vital insulin into the patient. The dosing must be precise down to the microliter to keep the patient’s metabolism in balance. This is guaranteed by the extremely precise functioning of the new pump’s drive, which pushes a punch into the replaceable insulin carpule.

The distance covered determines the delivery volume. A separately measured blood sugar level is the basis for controlling the pump. The target-actual comparison employs various parameters, which are measured within the pump itself—especially based on a force measurement within the drive.

To facilitate a reliable measurement, as little friction as possible among all the drive’s components is extremely important. This poses a major challenge especially for the feed seal. A rod seal seated on the driveshaft (threaded sleeve) for the punch is designed to seal the interior operation of the drive toward the carpule space and protect against the penetration of dirt particles or water.

Freudenberg Sealing Technologies was able to resolve the contradiction between minimal friction and high leak tightness with the combination of an innovative seal and a high performance lubricant from Klüber Lubrication.

The rod seal provided in the solution also has an especially smooth and low-friction surface. A nanotechnology process developed by Freudenberg Sealing Technologies not only reduces roughness. It also decreases the tendency of the elastomer to adhere more strongly to the threaded sleeve when the device is stopped. This allows very even torque progression.

The already very low frictional torque—four thousandths of a newton meter—can even be cut in half with the application of a PFPE lubricant. PFPE stands for perfluorinated polyether oils, whose stability is significantly superior to that of conventional lubricants even under extreme conditions—they are even used in space flight.

In just one year of close cooperation, the “lube & seal” concept of Freudenberg Sealing Technologies and Klüber Lubrication led to success. René Mathys, who is responsible for the development of infusion systems at Ypsomed, summed up the situation: “Without the combination of an innovative sealing solution and the right lubricant, we would not have reached our goal.”

Series production of the mylife YpsoPump has begun at Burgdorf in Switzerland. The first patients in the Netherlands, the U.K. and Germany have been carrying them since autumn, and the device has already been honored with two awards for its design.

For reasons related to safety, the lifespan of each insulin pump is limited to four years, which amounts to about 35,000 hours of operation. By comparison, the operating life for a car is only about 2,000 hours.

The seal provided by Freudenberg Sealing Technologies is superbly prepared for this heavy usage. After all, minimum friction also means minimum wear. That’s important for a device to which patients entrust their lives.

Freudenberg Sealing Technologies
freudenberg.com

Speak Your Mind

*